Ex-Sarepta execs join new Atlas-backed muscular disease startup fueled by $50M
April 03, 2019 at 06:30 AM EDT
A new Atlas Venture-founded startup launched Wednesday, backed by $50 million, to develop drugs for a currently untreated form of muscular dystrophy and other muscle-based diseases.
